William Blair Investment Management LLC Trims Stake in ICU Medical, Inc. $ICUI

William Blair Investment Management LLC decreased its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 9.2% during the fourth quarter, Holdings Channel reports. The fund owned 210,766 shares of the medical instruments supplier’s stock after selling 21,402 shares during the period. William Blair Investment Management LLC’s holdings in ICU Medical were worth $30,070,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in ICUI. Covestor Ltd grew its holdings in shares of ICU Medical by 70.7% during the 3rd quarter. Covestor Ltd now owns 570 shares of the medical instruments supplier’s stock worth $68,000 after acquiring an additional 236 shares during the period. Strs Ohio grew its holdings in shares of ICU Medical by 60.0% during the 4th quarter. Strs Ohio now owns 800 shares of the medical instruments supplier’s stock worth $114,000 after acquiring an additional 300 shares during the period. Smartleaf Asset Management LLC grew its holdings in shares of ICU Medical by 11.6% during the 2nd quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock worth $128,000 after acquiring an additional 101 shares during the period. Headlands Technologies LLC purchased a new position in shares of ICU Medical during the 2nd quarter worth approximately $177,000. Finally, Allegheny Financial Group purchased a new position in shares of ICU Medical during the 4th quarter worth approximately $214,000. Hedge funds and other institutional investors own 96.10% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ICUI. Wall Street Zen upgraded ICU Medical from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Jefferies Financial Group upgraded ICU Medical to a “strong-buy” rating in a report on Thursday, May 7th. Weiss Ratings upgraded ICU Medical from a “sell (d)” rating to a “sell (d+)” rating in a report on Monday, May 11th. Piper Sandler cut their price target on ICU Medical from $178.00 to $163.00 and set an “overweight” rating on the stock in a research note on Friday, April 17th. Finally, KeyCorp cut their price target on ICU Medical from $180.00 to $164.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Two research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, ICU Medical presently has an average rating of “Buy” and a consensus target price of $169.00.

Insider Activity at ICU Medical

In related news, Director David C. Greenberg sold 2,424 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $122.91, for a total value of $297,933.84. Following the sale, the director owned 7,960 shares in the company, valued at $978,363.60. This represents a 23.34% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Virginia Ruth Sanzone sold 2,447 shares of the company’s stock in a transaction that occurred on Thursday, May 14th. The shares were sold at an average price of $124.08, for a total value of $303,623.76. Following the completion of the transaction, the vice president directly owned 19,460 shares in the company, valued at $2,414,596.80. This trade represents a 11.17% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 2.10% of the company’s stock.

ICU Medical Stock Performance

ICU Medical stock opened at $133.31 on Monday. The company has a quick ratio of 1.17, a current ratio of 2.34 and a debt-to-equity ratio of 0.60. The company has a market capitalization of $3.33 billion, a P/E ratio of 72.06, a PEG ratio of 1.92 and a beta of 0.74. The stock’s 50 day moving average is $125.37 and its 200 day moving average is $138.70. ICU Medical, Inc. has a twelve month low of $107.00 and a twelve month high of $160.29.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $1.97 earnings per share for the quarter, topping the consensus estimate of $1.78 by $0.19. The company had revenue of $525.77 million for the quarter, compared to the consensus estimate of $520.65 million. ICU Medical had a return on equity of 7.50% and a net margin of 2.15%.The firm’s quarterly revenue was down 12.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.72 EPS. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. On average, equities research analysts predict that ICU Medical, Inc. will post 6.5 earnings per share for the current fiscal year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.